Work

Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy

Year: 2026

Type: letter

Source: Journal of Clinical Oncology

DOI: 10.1200/jco-26-00940

Authors: Nadine M. Tung, Tianyu Li, Judy E. Garber

Institution: Dana-Farber Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7167615367

Cites: 2

Cited by:

Related to: 10